Exo- and Endo-Receptors in One
(d, J ) 8.0 Hz, 2 H), 7.90 (d, J ) 7.8 Hz, 2 H), 7.84 (t, J ) 7.8
Hz, 2 H), 7.58 (m, 5 H), 4.00 (t, J ) 6.8 Hz, 12 H), 3.70 (s, 6
H), 2.42 (t, J ) 7.4 Hz, 12 H), 1.93 (quintet, J ) 7.0 Hz, 12 H);
13C NMR (125 MHz, CDCl3) δ 156.6, 154.9, 150.8, 142.0, 136.9,
129.1, 128.9, 128.1, 127.6, 126.2, 121.6, 120.0, 102.7, 81.2, 80.7,
79.7, 77.5, 69.7, 36.6, 24.0; ES HRMS m/z (M + Na)+ calcd
996.3678, obsd 996.3604.
Bip yr id in e 4. A solution of 10 (40 mg, 0.12 mmol) in dry
THF (2 mL) was treated at rt with potassium hexamethyldisila-
zide (0.25 mL of 0.5 M in toluene). After 10 min, dibromide 8
(19 mg, 0.06 mmol) was introduced, and the reaction mixture
was refluxed overnight, cooled, quenched with water, and ex-
tracted with CH2Cl2 (5×). The volume of the combined organic
phases was reduced to the 10% level by evaporation under
reduced pressure, and the residue was chromatographed on
silica gel (elution with 5% methanol in CH2Cl2) followed by
recrystallization from CH2Cl2 gave 4 as a white solid: mp >
270 °C (15 mg, 30%); IR (neat, cm-1) 2946, 1072; 1H NMR (500
MHz, CDCl3) δ 7.98 (d, J ) 7.4 Hz, 2 H), 7.67 (t, J ) 7.8 Hz,
2 H), 6.84 (d, J ) 8.1 Hz, 2 H), 4.45 (s, 4 H), 4.00 (t, J ) 6.9
Hz, 12 H), 3.65 (s, 6 H), 2.35 (t, J ) 7.3 Hz, 12 H), 1.91 (quintet,
J ) 7.5 Hz, 12 H); 13C NMR (125 MHz, CDCl3) δ 162.2, 152.9,
139.3, 114.2, 111.4, 107.0, 80.0, 76.3, 69.6, 66.2, 36.3, 23.9; ES
HRMS m/z (M + Na)+ calcd 855.3311, obsd 855.3271.
CH2Cl2, and the combined organic phases were dried and
evaporated. The residue was chromatographed on silica gel
(elution with 1:1 CH2Cl2/hexanes) to furnish 0.17 g (72%) of
13 as a white solid: mp 174-175 °C; IR (neat, cm-1) 1574,
1
1435; H NMR (300 MHz, CDCl3) δ 8.02 (d, J ) 7.3 Hz, 2 H),
7.72 (t, J ) 7.5 Hz, 2 H), 7.53 (d, J ) 6.8 Hz, 4 H), 7.39 (m, 6
H), 6.82 (d, J ) 8.2 Hz, 2 H), 5.53 (s, 4 H); 13C NMR (75 MHz,
CDCl3) δ 162.8, 153.3, 139.4, 137.6, 128.5, 128.1, 127.8, 113.9,
111.3, 67.4; ES HRMS m/z (M + Na)+ calcd 391.1417, obsd
391.1418.
Ter p yr id in e 14. Reaction of 9 (0.20 g, 0.43 mmol) with
benzyl alcohol (0.18 mL, 1.7 mmol) according to the pre-
described protocol resulted in the isolation of 0.11 g (50%) of
14 as a white solid: mp 158-159 °C; IR (neat, cm-1) 3064,
1
1582, 1266; H NMR (300 MHz, CDCl3) δ 8.58 (s, 2 H), 8.27
(d, J ) 7.5 Hz, 2 H), 7.79 (m, 4 H), 7.55 (m, 7 H), 7.39 (m, 6
H), 6.88 (d, J ) 8.2 Hz, 2 H), 5.56 (s, 4 H); 13C NMR (75 MHz,
CDCl3) δ 162.9, 155.8, 153,6, 150.0, 141.0, 139.5, 137.8, 129.1,
129.0, 128.5, 128.0, 127.8, 127.3, 118.8, 114.3, 111.6, 67.7; ES
HRMS m/z (M + Na)+ calcd 544.1995, obsd 544.2013.
Gen er a l P r oced u r e for Com p lexa tion Exp er im en ts
In volvin g 11, 13, or 14 w ith Cu Cl or F eCl2. Approximately
1.0 mg of the ligand was dissolved in ∼0.5 mL of a 1:1 mixture
of CH3CN and CHCl3. To this solution was added the proper
quantity of a 0.04 or 0.08 M solution of CuCl in the same
solvent system or of FeCl2 in methanol. After the addition, the
red or yellow solutions were evaporated in a stream of N2 to
furnish the complex in quantitative yield.
Ter p yr id in e 6. Reaction of 10 (50 mg, 0.15 mmol) in dry
THF (2.5 mL) sequentially with potassium hexamethyldisi-
lazide (0.30 mL of 0.5 M in toluene) and dibromide 9 (34.4
mg, 0.073 mmol) in a manner paralleling that described above
furnished 21 mg (30%) of 6 as a white solid: mp 191-193 °C;
For 15: orange solid; ES HRMS m/z (M+) calcd 775.2017,
obsd 775. 2015.
1
IR (neat, cm-1) 2944, 2874, 1581, 1074; H NMR (500 MHz,
For 16: pale orange solid; ES HRMS m/z (M+) calcd
1081.3174, obsd 1081.3180.
CDCl3) δ 8.60 (s, 2 H), 8.32 (d, J ) 7.4 Hz, 2 H), 7.85 (d, J )
7.2 Hz, 2 H), 7.80 (t, J ) 7.9 Hz, 2 H), 7.60 (t, J ) 7.2 Hz, 2
H), 7.53 (t, J ) 7.4 Hz, 1 H), 6.94 (d, J ) 8.1 Hz, 2 H), 4.56 (s,
4 H), 4.01 (t, J ) 6.4 Hz, 12 H), 3.67 (s, 6 H), 2.37 (t, J ) 7.4
Hz, 12 H), 1.91 (quintet, J ) 7.4 Hz, 12 H); 13C NMR (125
MHz, CDCl3) δ 162.9, 156.0, 153.8, 150.9, 139.9, 139.8, 129.5,
129.2, 127.9, 119.4, 115.2, 112.1, 107.6, 80.4, 76.8, 70.0, 66.5,
36.7, 24.4; ES HRMS m/z (M + Na)+ calcd 1008.3889, obsd
1008.3842.
For 17: red solid; ES HRMS m/z (M+2/2) calcd 549.1772,
obsd 549.1778.
Gen er a l P r oced u r e for Com p lexa tion Exp er im en ts
In volvin g 3, 5, a n d 6 w ith Cu Cl or F eCl2. Approximately
1.0 mg of the ligand was dissolved in ∼0.5 mL of a 1:1 mixture
of CH3CN and CHCl3. To this was added the proper µL
quantity of a 0.04 or 0.08 M CuCl in the same solvent system
or of FeCl2 in methanol. Subsequently, the red or yellow
solutions were freed of solvent under a stream of N2 to give
the complex in quantitative yield.
Bip yr id in e 11. To a mixture of 8 (0.25 g, 0.80 mmol), CuI
(18 mg, 12 mol %), and PdCl2(PPh3)2 (37 mg, 6 mol %) was
added triethylamine (10 mL) under N2. Phenylacetylene (0.18
mL, 1.67 mmol) was introduced dropwise, and overnight
stirring was maintained prior to quenching with water. The
aqueous layer was extracted with CH2Cl2, and the combined
organic phases were dried and concentrated. The residue was
chromatographed on silica gel (elution with 1:1 CH2Cl2/
hexanes) to provide 210 mg (74%) of 11 as a white solid: mp
194-195 °C (lit.16 mp 195.8-196.2 °C); IR (neat, cm-1) 2357,
For 18: orange solid; ES HRMS m/z (M+) calcd 1704.5839,
obsd 1704.5736.
For 19: orange solid; ES HRMS m/z (M+) calcd 2010.6996,
obsd 2010.7003.
For 20: red solid; ES HRMS m/z (M+2/2) calcd 1013.8683,
obsd 1013.8723.
Gen er a l P r oced u r e for Recor d in g UV-vis Absor p tion
Cu r ves. A specific weight of 1-5 mg of the ligand was
dissolved in 1:1 CH2CN/CHCl3 (1-5 mL). These solutions were
scanned in the region from 190 to 890 nm. These solutions
were individually treated with 0.25, 0.50, and 1.0 equiv of
LiClO4, CuCl, or FeCl2 solutions defined above. Scanning was
repeated at every stage.
Gen er a l P r oced u r e for Com p lexa tion Exp er im en ts
In volvin g 3-6 w ith LiClO4. Approximately 1.0 mg of ligands
3-6 was dissolved in ∼0.5 mL of a 1:1 mixture of CH3CN and
CHCl3. To each solution was added the proper microliter
quantity of 0.235 or 0.176 M LiClO4 in the same solvent
system. After the addition, either the solid that precipitates
or the resulting solution was freed of solvent under a stream
of N2 to provide the complex in quantitative yield.
For 21: obtained from 3 as a white solid that precipitates
immediately; ES HRMS m/z for C92H96LiN4O24+ calcd 1648.6603,
obsd 1648.6749.
1
1567; H NMR (300 MHz, CDCl3) δ 8.48 (d, J ) 7.9 Hz, 2 H),
7.81 (t, J ) 7.8 Hz, 2 H), 7.64 (m, 4 H), 7.56 (d, J ) 7.7 Hz, 2
H), 7.39 (m, 6 H); 13C NMR (75 MHz, CDCl3) δ 155.9, 142.8,
137.1, 132.0, 128.9, 128.3, 127.5, 122.3, 120.8, 89.0, 88.9.
Ter p yr id in e 12. To a mixture of 9 (0.25 g, 0.54 mmol), CuI
(12 mg, 12 mol %), and PdCl2(PPh3)2 (23 mg, 6 mol %) was
added triethylamine (10 mL) under N2. After the dropwise
introduction of phenylacetylene (0.29 mL, 2.6 mmol), the
reaction mixture was processed in the above manner to give
190 mg (70%) of 12 as a white solid: mp 219-220 °C; IR (neat,
1
cm-1) 3060, 2360, 1575, 1400; H NMR (300 MHz, CDCl3) δ
8.82 (s, 2 H), 8.62 (d, J ) 7.9 Hz, 2 H), 7.93 (d, J ) 7.1 Hz, 2
H), 7.87 (t, J ) 7.8 Hz, 2 H), 7.67 (m, 4 H), 7.59 (d, J ) 7.4 Hz,
2 H), 7.45 (m, 3 H), 7.39 (m, 6 H); 13C NMR (75 MHz, CDCl3)
δ 156.7, 155.0, 150.7, 146.9, 142.8, 138.1, 137.0, 132.1, 129.0,
128.9, 128.4, 127.5, 127.4, 122.4, 120.6, 119.7, 89.1, 89.0; ES
HRMS m/z (M + Na)+ calcd 532.1784, obsd 532.1782.
For 22: obtained as a white solid after solvent evaporation;
ES HRMS m/z for C114H110LiN6O24Na+2 calcd 988.8826, obsd
988.8888.
For 23: obtained as a white solid after solvent evaporation;
ES HRMS m/z for C88H104LiN4O28Na+2 calcd 847.3442, obsd
847.3429.
Bip yr id in e 13. A cold (0 °C) solution of 8 (0.20 g, 0.64
mmol) in dry THF (15 mL) was treated with potassium
hexamethyldisilazide (5.1 mL of 0.5 M in toluene) and stirred
for 20 min prior to the introduction of benzyl alcohol (0.26 mL,
2.55 mmol). The reaction mixture was heated to reflux for 3 h
and quenched with water. The product was extracted into
J . Org. Chem, Vol. 69, No. 10, 2004 3269